ATE399204T1 - Humanes endogenes retrovirus - Google Patents

Humanes endogenes retrovirus

Info

Publication number
ATE399204T1
ATE399204T1 AT00946988T AT00946988T ATE399204T1 AT E399204 T1 ATE399204 T1 AT E399204T1 AT 00946988 T AT00946988 T AT 00946988T AT 00946988 T AT00946988 T AT 00946988T AT E399204 T1 ATE399204 T1 AT E399204T1
Authority
AT
Austria
Prior art keywords
mtv
human
endogene
retrovirus
present
Prior art date
Application number
AT00946988T
Other languages
English (en)
Inventor
Robert F Garry
Original Assignee
Univ Tulane
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Tulane filed Critical Univ Tulane
Application granted granted Critical
Publication of ATE399204T1 publication Critical patent/ATE399204T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/12011—Betaretrovirus, e.g. mouse mammary tumour virus
    • C12N2740/12022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/826—Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT00946988T 1999-06-30 2000-06-30 Humanes endogenes retrovirus ATE399204T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14162699P 1999-06-30 1999-06-30

Publications (1)

Publication Number Publication Date
ATE399204T1 true ATE399204T1 (de) 2008-07-15

Family

ID=22496493

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00946988T ATE399204T1 (de) 1999-06-30 2000-06-30 Humanes endogenes retrovirus

Country Status (14)

Country Link
US (1) US6670466B1 (de)
EP (1) EP1190055B1 (de)
JP (1) JP4934258B2 (de)
AT (1) ATE399204T1 (de)
AU (1) AU778027B2 (de)
CA (1) CA2369848C (de)
DE (1) DE60039295D1 (de)
DK (1) DK1190055T3 (de)
ES (1) ES2307521T3 (de)
HK (1) HK1046535B (de)
MX (1) MXPA01013388A (de)
NO (1) NO331637B1 (de)
PT (1) PT1190055E (de)
WO (1) WO2001000829A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100440852B1 (ko) * 2001-05-10 2004-07-19 주식회사 바이로메드 레트로바이러스에 특이적인 올리고뉴클레오티드 프라이머및 이를 이용한 레트로바이러스 농도 측정방법
US7056731B1 (en) 2001-06-22 2006-06-06 Mayo Foundation For Medical Education And Research Sulfotransferase SULT2A1 sequence variants
DE10309368A1 (de) * 2002-08-06 2004-02-26 Aventis Behring Gmbh Intellectual Property/Legal Pharmazeutische Zubereitung mit RNA als Cofaktor der Hämostase
CA2553455A1 (en) * 2004-01-21 2005-08-11 Gilead Sciences, Inc. Use of adefovir or tenofovir for inhibiting mmtv-like viruses involved in breast cancer and primary biliary cirrhosis
WO2005073728A1 (en) * 2004-01-29 2005-08-11 Yissum Research Development Company Of The Hebrew University Of Jerusalem Method for diagnosing and treatment of breast cancer and pharmaceuticals copmsition and kit for same
US20070110760A1 (en) * 2005-01-14 2007-05-17 Monroe John G Methods and compositions targeting viral and cellular ITAM motifs, and use of same in identifying compounds with therapeutic activity
US20090297530A1 (en) * 2006-05-22 2009-12-03 Feng Wang-Johanning Herv-k antigens, antibodies, and methods
EP2529020B1 (de) * 2010-01-28 2018-04-25 The Children's Hospital of Philadelphia Skalierbare herstellungsplattform zur reinigung von virenvektoren und gereinigte virenvektoren zur verwendung in gentherapien
US12016844B2 (en) 2019-07-02 2024-06-25 Virago Vax Inc. Mammary tumor virus suppression
US12029783B2 (en) * 2019-07-02 2024-07-09 Virago Vax Inc. Mammary tumor virus vaccine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5686247A (en) * 1995-11-09 1997-11-11 Mount Sinai School Of Medicine Of The City University Of New York Detection of mammary tumor virus env gene-like sequences in human breast cancer

Also Published As

Publication number Publication date
PT1190055E (pt) 2008-09-03
MXPA01013388A (es) 2002-07-02
JP4934258B2 (ja) 2012-05-16
WO2001000829A2 (en) 2001-01-04
AU778027B2 (en) 2004-11-11
WO2001000829A8 (en) 2001-06-14
CA2369848A1 (en) 2001-01-04
WO2001000829A3 (en) 2002-01-10
CA2369848C (en) 2011-09-20
AU6066700A (en) 2001-01-31
NO331637B1 (no) 2012-02-13
ES2307521T3 (es) 2008-12-01
JP2003507050A (ja) 2003-02-25
EP1190055B1 (de) 2008-06-25
DK1190055T3 (da) 2008-09-22
US6670466B1 (en) 2003-12-30
EP1190055A2 (de) 2002-03-27
DE60039295D1 (de) 2008-08-07
NO20016296L (no) 2002-02-25
WO2001000829A9 (en) 2002-07-25
HK1046535B (en) 2009-02-27
NO20016296D0 (no) 2001-12-20
HK1046535A1 (en) 2003-01-17

Similar Documents

Publication Publication Date Title
ATE446365T1 (de) Menschliches fgf-21 gen und genexpressionsprodukte
DE60039295D1 (de) Humanes endogenes retrovirus
PT93393A (pt) Processo para a preparacao de vacinas e de agentes de diagnostico que contem regioes imunogenicas de proteina e7do virus do papiloma humano do tipo 16 ou anticorpos suscitados contra estas regioes
DE69435075D1 (de) , die signalsequenzpeptide des endoplasmatischen reticulums und mindestens ein anderes peptid codieren, deren verwendung in impfstoffen und zur behandlung von krankheiten
ATE376559T1 (de) Methoden der verhinderung und behandlung der alzheimer'schen krankheit
ATE275630T1 (de) Fas ligand ähnliches protein, seine herstellung und verwendung
EA200300381A1 (ru) Нуклеиновые кислоты и полипептиды нового рецептора
DE68903846D1 (de) Neue galenische form von fenofibrat.
EA200400565A1 (ru) Конъюгаты химически модифицированного гормона роста человека
ATE141946T1 (de) Hiv-2-virusvarianten
NO2001018I2 (no) Rasburicase
DE60024100D1 (de) Von dem syndrom der weissen flecken virus abgeleitete proteine und deren verwendungen
PT1417222E (pt) Polipéptidos isolados baseados no epítopo neutralizante da proteína p17 de vih, úteis como vacinas, e anticorpos antip17 neutralizantes que reconhecem especificamente o referido polipéptido neutralizante
ATE265226T1 (de) Verwendung von wolinella succinogenes asparaginase zur behandlung von asparagin- abhängiger krankheiten
DK1536006T3 (da) Cancerantigener og anvendelse deraf
ATE403726T1 (de) Cytokin-proteinfamilie
WO2001043693A3 (en) Polynucleotide vaccines expressing codon optimized hiv-1 nef and modified hiv-1 nef
TR200103638T2 (tr) IL-8 Reseptör antagonistleri
TR200000610T2 (tr) IL-8 reseptör karşıtları.
TR199701666A2 (xx) �i�manl��a kar�� proteinler
ATE323176T1 (de) Nachweis von brusttumorvirus-artigen sequenzen in brustkrebs bei menschen
HU896176D0 (en) Method for producing of protease, reverse transcriptase and endonuclease of retrovirus
NO874704D0 (no) Minaktivin fremstilt ved rekombinant dna-teknikk.
DE60124380D1 (de) Angiogenese-assoziierte proteine und dafür kodierende nukleinsäure
ATE323772T1 (de) Regulatorische sequenzen des humanen mcp-1 gens

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1190055

Country of ref document: EP